These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6997204)

  • 1. [Inhibitors of folic acid metabolism (author's transl)].
    Drews J
    Infection; 1980; 8 Suppl 3():S 268-75. PubMed ID: 6997204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
    Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
    J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Environment and genetics in the etiology of cleft lip and cleft palate with reference to the role of folic acid].
    Bianchi F; Calzolari E; Ciulli L; Cordier S; Gualandi F; Pierini A; Mossey P
    Epidemiol Prev; 2000; 24(1):21-7. PubMed ID: 10748547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
    Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
    Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
    Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
    Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences among dihydrofolate reductases as a basis for chemotherapy.
    Hitchings GH
    Postgrad Med J; 1969 Nov; 45():Suppl:7-10. PubMed ID: 5361314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism of aminoanalogues of folate (author's transl)].
    Grzelakowska-Sztabert B
    Postepy Biochem; 1977 Nov; 23(4):559-78. PubMed ID: 593975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of tomizine (4-methoxy-6-aminopyrimido (4,5-b) (1,4)thiazine hydrochloride) on the physicochemical properties of the enzymes of folic acid metabolism--dihydrofolate reductase and nonspecific dihydrofolate reductase].
    Andreeva NA; Tongur AM; Kuznetsov BA; Shumakovoch GP; Gadzhieva AG
    Izv Akad Nauk SSSR Biol; 1983; (5):766-70. PubMed ID: 6630719
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects and mechanism of action of dihydrofolate reductase inhibitors.
    Hartman PG
    J Chemother; 1993 Dec; 5(6):369-76. PubMed ID: 8195828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
    Assaraf YG; Ifergan I; Kadry WN; Pinter RY
    J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The folic acid requirement and metabolism].
    Müller HE
    Dtsch Med Wochenschr; 1995 Sep; 120(38):1285-9. PubMed ID: 7555631
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of folates and folic acid antagonists in cancer chemotherapy.
    NCI Monogr; 1987; (5):1-223. PubMed ID: 3431587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transport and metabolism of folate in animal cells and microorganisms (author's transl)].
    Grzelakowska-Sztabert B
    Postepy Biochem; 1976; 22(3):345-85. PubMed ID: 995773
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates.
    Sierra EE; Goldman ID
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):11-23. PubMed ID: 10598550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate and antifolate pharmacology.
    Kamen B
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Folic acid metabolism during pregnancy in Japan--clinical aspects (author's transl)].
    Ide N
    Igaku Kenkyu; 1978 Aug; 48(6):493-507. PubMed ID: 749507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.